Zobuxa 15 mg tablets for cats and small dogs
Zobuxa 15 mg tablets for cats and small dogs
Authorised
- Enrofloxacin
Product identification
Medicine name:
Zobuxa 15 mg tablets for cats and small dogs
ZOBUXA
Active substance:
- Enrofloxacin
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Enrofloxacin15.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Available in:
-
Italy
Package description:
- (ID2) 100 Tablet: unspecified outer container with 1 Blister (Aluminium) with 100 Tablet
- (ID1) 10 Tablet: unspecified outer container with 1 Blister (Aluminium) with 10 Tablet
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Elanco France S.A.S
Responsible authority:
- Ministry Of Health
Authorisation number:
- 104350
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0197/001
Concerned member states:
-
Austria
-
Czechia
-
Hungary
-
Ireland
-
Italy
-
Poland
-
Portugal
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 14/02/2022
How useful was this page?:
